9 Ovarian Cancer Clinical Trials in Miami Beach, FL (2026)

Q: How do I join a clinical trial in Miami Beach?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami Beach research site will contact you.

Recruiting Ovarian Cancer Studies in Miami Beach

NCT07318558Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Researchers are looking for new ways to treat ovarian cancer (OC). Current treatment for OC may start with surgery to remove as much of the cancer as possible. After surgery, people may receive chemot...

Miami Beach, FLPHASE3900 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06161025Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

This study will evaluate the safety and efficacy of R-DXd therapy in participants with ovarian, peritoneal, or fallopian tube cancer....

Miami Beach, FLPHASE2860 participantsDaiichi Sankyo

View Study Details

NCT06824467Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

The main goals of this study are to learn about the safety of sacituzumab tirumotecan with bevacizumab and if people tolerate it; and If people who take sacituzumab tirumotecan with or without bevaciz...

Miami Beach, FLPHASE3770 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06819007Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

This clinical trial is designed to evaluate the efficacy and safety of T-DXd in combination with bevacizumab versus bevacizumab monotherapy as first-line maintenance therapy, in participants with huma...

Miami Beach, FLPHASE3582 participantsDaiichi Sankyo

View Study Details

NCT05128825Recruiting

A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

This is a multi-part Phase 2 study to evaluate the efficacy and safety of azenosertib (ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Canc...

Miami Beach, FLPHASE2310 participantsK-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

View Study Details

NCT06906341Recruiting

Relacorilant in Combination With Nab-paclitaxel and Bevacizumab in Advanced, Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

This is a Phase 2, single-arm, open-label study to evaluate efficacy and safety of intermittent dosing of relacorilant in combination with nab-paclitaxel and bevacizumab in patients with ovarian cance...

Miami Beach, FLPHASE2270 participantsCorcept Therapeutics

View Study Details

NCT06072781Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (ICT) in subjects with recurrent LGSOC who have progr...

Miami Beach, FLPHASE3270 participantsVerastem, Inc.

View Study Details

NCT06234423Recruiting

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

This phase 1 study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors....

Miami Beach, FLPHASE1263 participantsOnCusp Therapeutics, Inc.

View Study Details

NCT07023627Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With Cyclin E1 Overexpression....

Miami Beach, FLPHASE2160 participantsIncyte Corporation

View Study Details

About Ovarian Cancer Clinical Trials in Miami Beach

Ovarian cancer originates in the ovaries or fallopian tubes and is often called a "silent killer" due to subtle early symptoms. It is the fifth leading cause of cancer death among women. Treatment typically involves surgery and chemotherapy, with newer targeted therapies showing promise.

There are currently 9 ovarian cancer clinical trials recruiting participants in Miami Beach, FL. These studies are seeking a combined 4,385 participants. Research is being sponsored by Merck Sharp & Dohme LLC, Daiichi Sankyo, K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ovarian Cancer Clinical Trials in Miami Beach — FAQ

Are there ovarian cancer clinical trials in Miami Beach?

Yes, there are 9 ovarian cancer clinical trials currently recruiting in Miami Beach, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Miami Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami Beach research site will contact you about next steps.

Are clinical trials in Miami Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami Beach studies also compensate for your time and travel.

What ovarian cancer treatments are being tested?

The 9 active trials in Miami Beach are testing new therapies including novel drugs, biologics, and treatment approaches for ovarian cancer.

Data updated July 22, 2026 from ClinicalTrials.gov